Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATF4 | P18848 | 7/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22956444 | 0.95 | OPRK1 (0.43) | OPRK1KMT2AATF4 | |
| SCHEMBL22956704 | 0.85 | ATF4 (0.40) | ATF4 | |
| SCHEMBL22627904 | 0.82 | ATF4 (0.51) | OPRK1KMT2AATF4 | |
| SCHEMBL22628076 | 0.82 | ATF4 (0.43) | ATF4 | |
| SCHEMBL22956566 | 0.80 | ALDH1A1 (0.39) | ATF4 | |
| SCHEMBL22627603 | 0.80 | TP53 (0.49) | KMT2A | |
| SCHEMBL22956190 | 0.79 | ATF4 (0.43) | ATF4 | |
| SCHEMBL22628005 | 0.78 | ALDH1A1 (0.41) | KMT2AATF4 | |
| SCHEMBL22628292 | 0.78 | ATF4 (0.40) | KMT2AATF4 | |
| SCHEMBL22628188 | 0.78 | KMT2A (0.53) | KMT2AATF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200345727-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ABBVIE INC. | 2020-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200345727-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, DDIT3 | OPRK1 680/4885KMT2A 4320/4885ATF4 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.